0001127602-20-028537.txt : 20201109 0001127602-20-028537.hdr.sgml : 20201109 20201109184015 ACCESSION NUMBER: 0001127602-20-028537 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201105 FILED AS OF DATE: 20201109 DATE AS OF CHANGE: 20201109 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Flessner Kyle M CENTRAL INDEX KEY: 0001751966 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-03761 FILM NUMBER: 201299167 MAIL ADDRESS: STREET 1: 12500 TI BOULEVARD CITY: DALLAS STATE: TX ZIP: 75243 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TEXAS INSTRUMENTS INC CENTRAL INDEX KEY: 0000097476 STANDARD INDUSTRIAL CLASSIFICATION: SEMICONDUCTORS & RELATED DEVICES [3674] IRS NUMBER: 750289970 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: P.O. BOX 660199 CITY: DALLAS STATE: TX ZIP: 75266 BUSINESS PHONE: 9729953773 MAIL ADDRESS: STREET 1: 12500 TI BLVD STREET 2: PO BOX 660199 CITY: DALLAS STATE: TX ZIP: 75266 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2020-11-05 0000097476 TEXAS INSTRUMENTS INC TXN 0001751966 Flessner Kyle M 12500 TI BOULEVARD DALLAS TX 75243 1 Sr. Vice President Common Stock 2020-11-05 4 M 0 25000 52.93 A 78117 D Common Stock 2020-11-05 4 S 0 25000 155.1445 D 53117 D Common Stock 2020-11-09 4 M 0 24955 52.93 A 78072 D Common Stock 2020-11-09 4 S 0 24955 161.6307 D 53117 D NQ Stock Option (Right to Buy) 52.93 2020-11-05 4 M 0 25000 0 D 2026-01-29 Common Stock 25000 24955 D NQ Stock Option (Right to Buy) 52.93 2020-11-09 4 M 0 24955 0 D 2026-01-29 Common Stock 24955 0 D The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $155.0404 to $155.235. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $161.60 to $161.675. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. The option becomes exercisable in four equal annual installments beginning on January 29, 2017. /s/ Katharine Kane, Attorney In Fact 2020-11-09